Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02655822 |
|---|---|
| Brief Title: | Phase 1/1b Study to Evaluate the Safety and Tolerability of Ciforadenant Alone and in Combination With Atezolizumab in Advanced Cancers |
| First Submitted : | January 8, 2016 |
| First Submitted that Met QC Criteria : | January 13, 2016 |
| First Posted : | January 14, 2016 (Estimate) |
| Last Update Submitted that Met QC Criteria : | August 27, 2021 |
| Last Update Posted : | August 30, 2021 |